Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Two painkillers add up to one marketing battle

Article Abstract:

Two new drugs that relieve pain for arthritis sufferers will soon compete for the same patients via their doctors. Searle, Monsanto's drug unit, will co-market Celebrex with Pfizer as soon as the FDA approves it early next year. Merck's Vioxx is not expected to gain approval until a few months later, but the drug needs to be taken only once a day as opposed to Celebrex's twice a day dose, thought to be an advantage for Vioxx. The chief benefit from taking either drug, and shown in clinical trials, is that these drugs are much gentler on the stomach lining than currently available analgesics.

Author: Langreth, Robert, Burton, Thomas M.
Publisher: Dow Jones & Company, Inc.
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
Marketing procedures, Pharmaceutical preparations, Licensing/Sales Agreements, Demographics, Antiarthritic Analgesic Preps, Pharmaceutical industry, Marketing, Abstract, Arthritis, G.D. Searle and Co., Antiarthritic agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Merk, Astra reach restructuring pact

Article Abstract:

Merck Co. and Sweden's Astra AB are in negotiations to restructure their longstanding joint venture. Sources say Astra will gain control of the venture, and Merck will give up voting rights and management control for royalty payments. Merck received half the U.S. business from Astra years ago in perpetuity. Astra is said to have the right to repurchase the ownership of Merck in 2008. While Merck will retain an ownership position, Astra will look for a merger partner.

Comment:

Restructure joint venture with Merck Co.

Author: Lipin, Steven, Langreth, Robert
Publisher: Dow Jones & Company, Inc.
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
Joint ventures, Sweden, Pharmaceutical Preparations, Astra AB, Article

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Drugs, Merck & Company Inc.
Similar abstracts:
  • Abstracts: Apple's latest overhaul to concentrate on cutting product line, bureaucracy
  • Abstracts: International linkages in Euromark futures markets: information transmission and market integration. Valuation of a European futures option in the BIFFEX market
  • Abstracts: EU panels clears MCI plan to sell Internet assets. MCI is selling wholesale Internet unit, but European trust issues may remain
  • Abstracts: Clinton to punish insurers who deny health coverage. Medicare contractor admits longtime pattern of fraud. White House plans Medicaid coverage of Viagra by states
  • Abstracts: Boeing to shift some jet output to Long Beach to ease strain
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.